{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:17:00Z","timestamp":1788301020559,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40266-026-01302-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:34:41Z","timestamp":1779464081000},"page":"605-620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Guideline-Directed Heart Failure Pharmacotherapy in Adults Aged \u226575 Years: Evidence Gaps, Tolerability, and Implications for Clinical Practice"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8002-4845","authenticated-orcid":false,"given":"R\u00e9mi","family":"Esser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Maurou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Larbaneix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mondragon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Farges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Nisse Durgeat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Harboun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"10","key":"1302_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Anker SD, Dahlstr\u00f6m U, Filippatos G, Ponikowski P, Zannad F, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013;15(10):1173\u201384. https:\/\/doi.org\/10.1093\/eurjhf\/hft134.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"1302_CR2","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(12):1574\u201385. https:\/\/doi.org\/10.1002\/ejhf.813.","journal-title":"Eur J Heart Fail"},{"issue":"37","key":"1302_CR3","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195. (Erratum in: Eur Heart J. 2024 Jan 1;45(1):53. doi: 10.1093\/eurheartj\/ehad613.).","journal-title":"Eur Heart J"},{"issue":"6","key":"1302_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ejhf.566","volume":"18","author":"MG Crespo-Leiro","year":"2016","unstructured":"Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18(6):613\u201325. https:\/\/doi.org\/10.1002\/ejhf.566.","journal-title":"Eur J Heart Fail"},{"issue":"10120","key":"1302_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(17)32520-5.","journal-title":"Lancet"},{"issue":"1","key":"1302_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7\u201311. https:\/\/doi.org\/10.15420\/cfr.2016:25:2.","journal-title":"Card Fail Rev"},{"issue":"20","key":"1302_CR7","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","volume":"70","author":"KS Shah","year":"2017","unstructured":"Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476\u201386. https:\/\/doi.org\/10.1016\/j.jacc.2017.08.074.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"1302_CR8","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","unstructured":"CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429\u201335. https:\/\/doi.org\/10.1056\/NEJM198706043162301.","journal-title":"N Engl J Med"},{"issue":"5","key":"1302_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"S Yusuf","year":"1991","unstructured":"SOLVD Investigators, Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325(5):293\u2013302. https:\/\/doi.org\/10.1056\/NEJM199108013250501.","journal-title":"N Engl J Med"},{"key":"1302_CR10","doi-asserted-by":"crossref","unstructured":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"issue":"9169","key":"1302_CR11","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"Effect of metoprolol CR\/XL in chronic heart failure","year":"1999","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure. Metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353(9169):2001\u20137.","journal-title":"Lancet"},{"issue":"10","key":"1302_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341(10):709\u201317. https:\/\/doi.org\/10.1056\/NEJM199909023411001.","journal-title":"N Engl J Med"},{"issue":"1","key":"1302_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1009492.","journal-title":"N Engl J Med"},{"issue":"11","key":"1302_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa1409077.","journal-title":"N Engl J Med"},{"issue":"21","key":"1302_CR15","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303.","journal-title":"N Engl J Med"},{"issue":"9744","key":"1302_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","volume":"376","author":"M B\u00f6hm","year":"2010","unstructured":"B\u00f6hm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376(9744):886\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(10)61259-7.","journal-title":"Lancet"},{"issue":"9386","key":"1302_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/s0140-6736(03)14282-1","volume":"362","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362(9386):759\u201366. https:\/\/doi.org\/10.1016\/s0140-6736(03)14282-1.","journal-title":"Lancet"},{"key":"1302_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2025-326305","author":"E Tan","year":"2026","unstructured":"Tan E, Meei-Wah C, Teo YH, Tan LF, Ho VWT, Lin W, et al. Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis. Heart. 2026. https:\/\/doi.org\/10.1136\/heartjnl-2025-326305.","journal-title":"Heart"},{"issue":"17","key":"1302_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.042367","volume":"14","author":"CM Nijskens","year":"2025","unstructured":"Nijskens CM, Handoko L, Remmelzwaal S, Ziesemer KA, Muller M. Efficacy and safety of heart failure treatment according to frailty status: a systematic review. J Am Heart Assoc. 2025;14(17):e042367. https:\/\/doi.org\/10.1161\/JAHA.125.042367.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1302_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bcp.16223","volume":"91","author":"MH Duong","year":"2025","unstructured":"Duong MH, Gnjidic D, McLachlan AJ, Redston MR, Goyal P, Mathieson S, et al. The effect of down-titration and discontinuation of heart failure pharmacotherapy in older people: a systematic review and meta-analysis. Br J Clin Pharmacol. 2025;91(1):23\u201337. https:\/\/doi.org\/10.1111\/bcp.16223.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1302_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s40266-022-00957-8","volume":"39","author":"MH Duong","year":"2022","unstructured":"Duong MH, Gnjidic D, McLachlan AJ, Sakiris MA, Goyal P, Hilmer SN. The prevalence of adverse drug reactions and adverse drug events from heart failure medications in frail older adults: a systematic review. Drugs Aging. 2022;39(8):631\u201343. https:\/\/doi.org\/10.1007\/s40266-022-00957-8.","journal-title":"Drugs Aging"},{"issue":"15","key":"1302_CR22","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413\u201324. https:\/\/doi.org\/10.1056\/NEJMoa2022190.","journal-title":"N Engl J Med"},{"issue":"3","key":"1302_CR23","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.ijcard.2012.12.069","volume":"168","author":"D Niederseer","year":"2013","unstructured":"Niederseer D, Thaler CW, Niederseer M, Niebauer J. Mismatch between heart failure patients in clinical trials and the real world. Int J Cardiol. 2013;168(3):1859\u201365. https:\/\/doi.org\/10.1016\/j.ijcard.2012.12.069.","journal-title":"Int J Cardiol"},{"issue":"10","key":"1302_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jamacardio.2018.2559","volume":"3","author":"AS Tahhan","year":"2018","unstructured":"Tahhan AS, Vaduganathan M, Greene SJ, Fonarow GC, Fiuzat M, Jessup M, et al. Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review. JAMA Cardiol. 2018;3(10):1011\u20139. https:\/\/doi.org\/10.1001\/jamacardio.2018.2559.","journal-title":"JAMA Cardiol"},{"issue":"10367","key":"1302_CR25","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400(10367):1938\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(22)02076-1.","journal-title":"Lancet"},{"issue":"2","key":"1302_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.15420\/cfr.2019.6.2","volume":"5","author":"D Stolfo","year":"2019","unstructured":"Stolfo D, Savarese G. Use of renin-angiotensin-aldosterone system inhibitors in older patients with heart failure and reduced ejection fraction. Card Fail Rev. 2019;5(2):70\u20133. https:\/\/doi.org\/10.15420\/cfr.2019.6.2.","journal-title":"Card Fail Rev"},{"issue":"5","key":"1302_CR27","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ahj.2005.10.022","volume":"151","author":"HP Brunner-La Rocca","year":"2006","unstructured":"Brunner-La Rocca HP, Buser PT, Schindler R, Bernheim A, Rickenbacher P, et al. Management of elderly patients with congestive heart failure\u2013design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Am Heart J. 2006;151(5):949\u201355. https:\/\/doi.org\/10.1016\/j.ahj.2005.10.022.","journal-title":"Am Heart J"},{"issue":"38","key":"1302_CR28","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/eurheartj\/ehv330","volume":"36","author":"PS Jhund","year":"2015","unstructured":"Jhund PS, Fu M, Bayram E, Chen CH, Negrusz-Kawecka M, Rosenthal A, et al. Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF. Eur Heart J. 2015;36(38):2576\u201384. https:\/\/doi.org\/10.1093\/eurheartj\/ehv330.","journal-title":"Eur Heart J"},{"issue":"10166","key":"1302_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393(10166):31\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(18)32590-X.","journal-title":"Lancet"},{"issue":"356","key":"1302_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j791","volume":"9","author":"M Schmidt","year":"2017","unstructured":"Schmidt M, Mansfield KE, Bhaskaran K, Nitsch D, S\u00f8rensen HT, Smeeth L, et al. Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study. BMJ. 2017;9(356):j791. https:\/\/doi.org\/10.1136\/bmj.j791.","journal-title":"BMJ"},{"issue":"18","key":"1302_CR31","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart failure with preserved ejection fraction: JACC Scientific Statement. J Am Coll Cardiol. 2023;81(18):1810\u201334. https:\/\/doi.org\/10.1016\/j.jacc.2023.01.049.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1302_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10741-018-9714-z","volume":"23","author":"B Upadhya","year":"2018","unstructured":"Upadhya B, Haykowsky MJ, Kitzman DW. Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions. Heart Fail Rev. 2018;23(5):609\u201329. https:\/\/doi.org\/10.1007\/s10741-018-9714-z.","journal-title":"Heart Fail Rev"},{"key":"1302_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2015.12.003","volume":"26","author":"BJ Buta","year":"2016","unstructured":"Buta BJ, Walston JD, Godino JG, Park M, Kalyani RR, Xue QL, et al. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53\u201361. https:\/\/doi.org\/10.1016\/j.arr.2015.12.003.","journal-title":"Ageing Res Rev"},{"issue":"9868","key":"1302_CR34","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(12)62167-9.","journal-title":"Lancet"},{"issue":"1","key":"1302_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cger.2010.08.008","volume":"27","author":"K Rockwood","year":"2011","unstructured":"Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med. 2011;27(1):17\u201326. https:\/\/doi.org\/10.1016\/j.cger.2010.08.008.","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"1302_CR36","doi-asserted-by":"publisher","DOI":"10.31083\/RCM26854","volume":"26","author":"L Wu","year":"2025","unstructured":"Wu L, Liu S, Zhang M, Xiong X. Prevalence and associated factors of frailty in patients with chronic heart failure: a systematic review and meta-analysis. Rev Cardiovasc Med. 2025;26(3):26854. https:\/\/doi.org\/10.31083\/RCM26854.","journal-title":"Rev Cardiovasc Med"},{"issue":"12","key":"1302_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026844","volume":"12","author":"T Kondo","year":"2023","unstructured":"Kondo T, Adachi T, Kobayashi K, Okumura T, Izawa H, Murohara T, et al. Physical frailty and use of guideline-recommended drugs in patients with heart failure and reduced ejection fraction. J Am Heart Assoc. 2023;12(12):e026844. https:\/\/doi.org\/10.1161\/JAHA.122.026844.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1302_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57\u201365. https:\/\/doi.org\/10.1517\/14740338.2013.827660.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"1302_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1472-8206.2007.00473.x","volume":"21","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007;21(3):217\u201330. https:\/\/doi.org\/10.1111\/j.1472-8206.2007.00473.x.","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"1302_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2215\/CJN.13541021","volume":"17","author":"M Epstein","year":"2022","unstructured":"Epstein M, Pecoits-Filho R, Clase CM, Sood MM, Kovesdy CP. Hyperkalemia with mineralocorticoid receptor antagonist use in people with CKD: understanding and mitigating the risks. Clin J Am Soc Nephrol. 2022;17(3):455\u20137. https:\/\/doi.org\/10.2215\/CJN.13541021.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1302_CR41","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","volume":"14","author":"JE Morley","year":"2013","unstructured":"Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392\u20137. https:\/\/doi.org\/10.1016\/j.jamda.2013.03.022.","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"1302_CR42","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12603-019-1273-z","volume":"23","author":"E Dent","year":"2019","unstructured":"Dent E, Morley JE, Cruz-Jentoft AJ, Woodhouse L, Rodr\u00edguez-Ma\u00f1as L, Fried LP, et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging. 2019;23(9):771\u201387. https:\/\/doi.org\/10.1007\/s12603-019-1273-z.","journal-title":"J Nutr Health Aging"},{"issue":"27","key":"1302_CR43","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1056\/NEJMsb042458","volume":"351","author":"ME Tinetti","year":"2004","unstructured":"Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870\u20134. https:\/\/doi.org\/10.1056\/NEJMsb042458.","journal-title":"N Engl J Med"},{"issue":"5","key":"1302_CR44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/eurjhf\/hfp041","volume":"11","author":"T Jaarsma","year":"2009","unstructured":"Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11(5):433\u201343. https:\/\/doi.org\/10.1093\/eurjhf\/hfp041.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1302_CR45","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jacc.2009.02.078","volume":"54","author":"SJ Goodlin","year":"2009","unstructured":"Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54(5):386\u201396. https:\/\/doi.org\/10.1016\/j.jacc.2009.02.078.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"1302_CR46","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1161\/CIR.0b013e31824f2173","volume":"125","author":"LA Allen","year":"2012","unstructured":"Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928\u201352. https:\/\/doi.org\/10.1161\/CIR.0b013e31824f2173.","journal-title":"Circulation"},{"issue":"6","key":"1302_CR47","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/archinternmed.2011.31","volume":"171","author":"A Cherubini","year":"2011","unstructured":"Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171(6):550\u20136. https:\/\/doi.org\/10.1001\/archinternmed.2011.31.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1302_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad082","volume":"52","author":"VA Goodwin","year":"2023","unstructured":"Goodwin VA, Low MSA, Quinn TJ, Cockcroft EJ, Shepherd V, Evans PH, et al. Including older people in health and social care research: best practice recommendations based on the INCLUDE framework. Age Ageing. 2023;52(6):afad082. https:\/\/doi.org\/10.1093\/ageing\/afad082.","journal-title":"Age Ageing"},{"issue":"17","key":"1302_CR49","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2018.02.059","volume":"71","author":"EZ Gorodeski","year":"2018","unstructured":"Gorodeski EZ, Goyal P, Hummel SL, Krishnaswami A, Goodlin SJ, Hart LL, et al. Domain management approach to heart failure in the geriatric patient: present and future. J Am Coll Cardiol. 2018;71(17):1921\u201336. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.059.","journal-title":"J Am Coll Cardiol"},{"key":"1302_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jclinepi.2018.11.014","volume":"107","author":"A Malmivaara","year":"2019","unstructured":"Malmivaara A. Generalizability of findings from randomized controlled trials is limited in the leading general medical journals. J Clin Epidemiol. 2019;107:36\u201341. https:\/\/doi.org\/10.1016\/j.jclinepi.2018.11.014.","journal-title":"J Clin Epidemiol"},{"key":"1302_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007228.pub2","volume":"8","author":"SC Inglis","year":"2010","unstructured":"Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev. 2010;8:CD007228. https:\/\/doi.org\/10.1002\/14651858.CD007228.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1302_CR52","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2020.28","volume":"7","author":"A Singhal","year":"2021","unstructured":"Singhal A, Cowie MR. Digital health: implications for heart failure management. Card Fail Rev. 2021;7:e08. https:\/\/doi.org\/10.15420\/cfr.2020.28.","journal-title":"Card Fail Rev"},{"issue":"10152","key":"1302_CR53","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(18)31880-4","volume":"392","author":"F Koehler","year":"2018","unstructured":"Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan BA, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018;392(10152):1047\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(18)31880-4.","journal-title":"Lancet"},{"issue":"5","key":"1302_CR54","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1002\/ehf2.14022","volume":"9","author":"L Guasti","year":"2022","unstructured":"Guasti L, Dilaveris P, Mamas MA, Richter D, Christodorescu R, Lumens J, et al. Digital health in older adults for the prevention and management of cardiovascular diseases and frailty. A clinical consensus statement from the ESC Council for Cardiology Practice\/Taskforce on Geriatric Cardiology, the ESC Digital Health Committee and the ESC Working Group on e-Cardiology. ESC Heart Fail. 2022;9(5):2808\u201322. https:\/\/doi.org\/10.1002\/ehf2.14022.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"1302_CR55","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jchf.2021.12.004","volume":"10","author":"MS Khan","year":"2022","unstructured":"Khan MS, Segar MW, Usman MS, Singh S, Greene SJ, Fonarow GC, et al. Frailty, guideline-directed medical therapy, and outcomes in HFrEF: from the GUIDE-IT trial. JACC Heart Fail. 2022;10(4):266\u201375. https:\/\/doi.org\/10.1016\/j.jchf.2021.12.004.","journal-title":"JACC Heart Fail."},{"key":"1302_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01244-w","author":"TN Nguyen","year":"2026","unstructured":"Nguyen TN, Woodward M, Butt JH, McMurray JJV, Lip GYH, Kaski JC. Optimizing cardiovascular pharmacotherapy in older adults with frailty. Nat Rev Cardiol. 2026. https:\/\/doi.org\/10.1038\/s41569-025-01244-w.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"1302_CR57","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ejhf.2483","volume":"24","author":"D Stolfo","year":"2022","unstructured":"Stolfo D, Lund LH, Becher PM, Orsini N, Thorvaldsen T, Benson L, et al. Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata. Eur J Heart Fail. 2022;24(6):1047\u201362. https:\/\/doi.org\/10.1002\/ejhf.2483.","journal-title":"Eur J Heart Fail"}],"updated-by":[{"DOI":"10.1007\/s40266-026-01308-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000}}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01302-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01302-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01302-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:43:55Z","timestamp":1783748635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01302-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01302-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: to correct Figure 1.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40266-026-01308-7","URL":"https:\/\/doi.org\/10.1007\/s40266-026-01308-7","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sophie Nisse Durgeat and Nicolas Pages are employed by NP Medical. All other authors declare that they have no conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript is a narrative review based exclusively on published data and did not involve human participants. Ethical approval was therefore not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Generative artificial intelligence tools were used solely to assist with language editing, clarity, and translation of the manuscript. The AI tools did not contribute to the study design, data collection, data analysis, interpretation of results, or scientific conclusions. All content was reviewed, edited, and approved by the authors, who take full responsibility for the accuracy and integrity of the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI-use statement"}},{"value":"Not applicable. The manuscript does not include any individual person\u2019s data in any form (images, videos, or identifiable details).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets used and\/or analyzed during the current study are available from the corresponding author (R.E.) on reasonable request. Due to patient privacy restrictions, data are not publicly available.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"RE conceived the review, defined the conceptual framework, and led the manuscript drafting. OM, ML, AM, ME, CF, and MH contributed to the literature review, data interpretation, and critical revision of the manuscript for important intellectual content. VP provided expert input on heart failure pharmacotherapy and critically reviewed the cardiology content. NP and SND contributed to telemonitoring perspectives, and editorial revision. All authors approved the final version of the manuscript and agree to be accountable for all aspects of the work.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}